AVE 16.7% 0.3¢ avecho biotechnology limited

Ann: FDA meeting provides guidance for TPM/Oxymorphone patch, page-6

  1. 11 Posts.
    lightbulb Created with Sketch. 9

    Two points of interest:

    1. The mean time for a 505 b pathway approval is approx 18 months. https://www.raps.org/regulatory-focus™/news-articles/2017/3/505(b)(2)-approval-pathway-not-necessarily-shorter-approval-times

    2. Two external experts. Who are they? Obviously commercial in-confidence. It suggests that a company is in early stage negotiations to partner.

 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
-0.001(16.7%)
Mkt cap ! $7.923M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $25 10K

Buyers (Bids)

No. Vol. Price($)
66 91668236 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 62801585 14
View Market Depth
Last trade - 10.43am 23/07/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.